메뉴 건너뛰기




Volumn 9, Issue 1, 2005, Pages 169-190

Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer

Author keywords

Antibody; Antibody dependent cell mediated cytotoxicity (ADCC); Fc receptor (FcR); Fc R; Fc RIIB; Intravenus immunoglobulin (IVIg)

Indexed keywords

ADALIMUMAB; ANTIBODY; CD20 ANTIGEN; CD23 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOKINE ANTIBODY; FC RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ANTIBODY; INTERLEUKIN 8; INTERLEUKIN 9 ANTIBODY; METHOTREXATE; MONOCLONAL ANTIBODY; RECOMBINANT ANTIBODY; RHUMAB E25; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 14744305640     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.9.1.169     Document Type: Review
Times cited : (17)

References (189)
  • 1
    • 0027925168 scopus 로고
    • New concepts about the mast cell
    • GALLI SJ: New concepts about the mast cell. N. Engl. J. Med. (1993) 328(4):257-265.
    • (1993) N. Engl. J. Med. , vol.328 , Issue.4 , pp. 257-265
    • Galli, S.J.1
  • 2
    • 0032970154 scopus 로고    scopus 로고
    • The high-affinity IgE receptor (Fc_RI) from physiology to pathology
    • KINET JP: The high-affinity IgE receptor (Fc_RI) from physiology to pathology. Ann. Rev. Immunol. (1999) 17 931-972.
    • (1999) Ann. Rev. Immunol. , vol.17 , pp. 931-972
    • Kinet, J.P.1
  • 3
    • 0036883552 scopus 로고    scopus 로고
    • Molecular aspects of allergy
    • MIESCHER SM, VOGEL M: Molecular aspects of allergy. Mol. Aspects Med. (2002) 236(6):413-462.
    • (2002) Mol. Aspects Med. , vol.236 , Issue.6 , pp. 413-462
    • Miescher, S.M.1    Vogel, M.2
  • 5
    • 0035546053 scopus 로고    scopus 로고
    • Effector lymphocytes in autoimmunity
    • SANTAMARIA P: Effector lymphocytes in autoimmunity. Curr. Opin. Immunol. (2001) 13(6):663-669.
    • (2001) Curr. Opin. Immunol. , vol.13 , Issue.6 , pp. 663-669
    • Santamaria, P.1
  • 6
    • 0035753991 scopus 로고    scopus 로고
    • Autoreactivity by design: Innate B and T lymphocytes
    • BENDELAC A, BONNEVILLE M, KEARNEY JF: Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. (2001) 1 3):177-186.
    • (2001) Nat. Rev. Immunol. , vol.1 , Issue.3 , pp. 177-186
    • Bendelac, A.1    Bonneville, M.2    Kearney, J.F.3
  • 7
    • 0034046181 scopus 로고    scopus 로고
    • Regulation of antibody responses via antibodies, complement, and Fc receptors
    • HEYMAN B: Regulation of antibody responses via antibodies, complement, and Fc receptors. Ann. Rev. Immunol. (2000) 18 709-737.
    • (2000) Ann. Rev. Immunol. , vol.18 , pp. 709-737
    • Heyman, B.1
  • 9
    • 0036676975 scopus 로고    scopus 로고
    • Roles of Fc receptors in autoimmunity
    • TAKAI T: Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. (2002) 2(8):580-592.
    • (2002) Nat. Rev. Immunol. , vol.2 , Issue.8 , pp. 580-592
    • Takai, T.1
  • 10
    • 0036888558 scopus 로고    scopus 로고
    • Fc receptors are major mediators of antibody based inflammation in autoimmunity
    • HOGARTH PM: Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. (2002) 14(6):798-802.
    • (2002) Curr. Opin. Immunol. , vol.14 , Issue.6 , pp. 798-802
    • Hogarth, P.M.1
  • 11
    • 5944247564 scopus 로고    scopus 로고
    • Fc α/μ receptor mediates endocytosis of IgM-coated microbes
    • SHIBUYA A, SAKAMOTA N, SHIMIZU Y et al.: Fc α/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. (2000) 1(5):441-446.
    • (2000) Nat. Immunol. , vol.1 , Issue.5 , pp. 441-446
    • Shibuya, A.1    Sakamota, N.2    Shimizu, Y.3
  • 12
    • 2342524131 scopus 로고    scopus 로고
    • The MHC Class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs
    • ROOPENIAN DC, CHRISTIANSON GJ, SPROULE TJ et al.: The MHC Class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J. Clin. Invest. (2004) 113(9):1328-1333.
    • (2004) J. Clin. Invest. , vol.113 , Issue.9 , pp. 1328-1333
    • Roopenian, D.C.1    Christianson, G.J.2    Sproule, T.J.3
  • 14
    • 0037994582 scopus 로고    scopus 로고
    • Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: Evidence for a genetic interaction between HLA-DRB1 and FCGR3A
    • KYOGOKU C, T SUCHIYA N, MATSUTA K, TOKUNAGA K: Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes. Immun. (2002) 3 8):488-493.
    • (2002) Genes Immun. , vol.3 , Issue.8 , pp. 488-493
    • Kyogoku, C.1    Suchiya, N.2    Matsuta, K.3    Tokunaga, K.4
  • 15
    • 0036945842 scopus 로고    scopus 로고
    • Variations in immune response genes and their associations with multifactorial immune disorders
    • TSUCHIYA N, OHASHI J, TOKUNAGA K: Variations in immune response genes and their associations with multifactorial immune disorders. Immunol. Rev. (2002) 190:169-181.
    • (2002) Immunol. Rev. , vol.190 , pp. 169-181
    • Tsuchiya, N.1    Ohashi, J.2    Tokunaga, K.3
  • 16
    • 0035983749 scopus 로고    scopus 로고
    • FcγRIIA-SLE Meta-Analysis Investigators: Role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis
    • KARASSA FB, TRIKALINOS TA, IOANNIDIS JP: FcγRIIA-SLE Meta-Analysis Investigators: role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis. Rheum. (2002) 46(6):1563-1571.
    • (2002) Arthritis Rheum. , vol.46 , Issue.6 , pp. 1563-1571
    • Karassa, F.B.1    Trikalinos, T.A.2    Ioannidis, J.P.3
  • 17
    • 0031283050 scopus 로고    scopus 로고
    • Analysis of FcγRII gene polymorphisms in Wegener's granulomatosis
    • EDBERG JC, WAINSTEIN E, WU J et al.: Analysis of FcγRII gene polymorphisms in Wegener's granulomatosis. Exp. Clin. Immunogenet. (1997) 14(3):183-195.
    • (1997) Exp. Clin. Immunogenet. , vol.14 , Issue.3 , pp. 183-195
    • Edberg, J.C.1    Wainstein, E.2    Wu, J.3
  • 18
    • 0033624966 scopus 로고    scopus 로고
    • Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis
    • NIETO A, CALIZ R, PASCUAL M, MATARAN L, GARCIA S, MARTIN J: Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum. (2000) 43(4):735-739.
    • (2000) Arthritis Rheum. , vol.43 , Issue.4 , pp. 735-739
    • Nieto, A.1    Caliz, R.2    Pascual, M.3    Mataran, L.4    Garcia, S.5    Martin, J.6
  • 19
    • 0037384322 scopus 로고    scopus 로고
    • FcγRIIIA-158V and rheumatoid arthritis: A confirmation study
    • MORGAN AW, KEYTE VH, BABBAGE SJ et al.: FcγRIIIA-158V and rheumatoid arthritis: a confirmation study. Rheumatology (2003) 42(4):528-533.
    • (2003) Rheumatology , vol.42 , Issue.4 , pp. 528-533
    • Morgan, A.W.1    Keyte, V.H.2    Babbage, S.J.3
  • 20
    • 0033188304 scopus 로고    scopus 로고
    • Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese
    • HATTA Y, TSUCHIYA N, OHASHI J et al.: Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun. (1999) 1(1):53-60.
    • (1999) Genes Immun. , vol.1 , Issue.1 , pp. 53-60
    • Hatta, Y.1    Tsuchiya, N.2    Ohashi, J.3
  • 21
    • 0034691322 scopus 로고    scopus 로고
    • The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
    • SONDERMANN P, HUBER R, OOSTUIZEN V, JACOB U: The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature (2000) 406(6793):267-273.
    • (2000) Nature , vol.406 , Issue.6793 , pp. 267-273
    • Sondermann, P.1    Huber, R.2    Oostuizen, V.3    Jacob, U.4
  • 22
    • 0034691520 scopus 로고    scopus 로고
    • Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcERI alpha
    • GARMAN SC, WURZBURG BA, TARCHEVSKAYA SS, KINET JP, JARDETZKY TS: Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcERI alpha. Nature (2000) 406(6793):259-266.
    • (2000) Nature , vol.406 , Issue.6793 , pp. 259-266
    • Garman, S.C.1    Wurzburg, B.A.2    Tarchevskaya, S.S.3    Kinet, J.P.4    Jardetzky, T.S.5
  • 23
    • 0037497304 scopus 로고    scopus 로고
    • Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc
    • HERR AB, BALLISTER ER, BJORKMAN PJ: Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature (2003) 423 6940):614-620.
    • (2003) Nature , vol.423 , Issue.6940 , pp. 614-620
    • Herr, A.B.1    Ballister, E.R.2    Bjorkman, P.J.3
  • 24
    • 0035844212 scopus 로고    scopus 로고
    • The structure of a human Type III Fcγ receptor in complex with Fc
    • RADAEV S, MOTYKA S, FRIDMAN WH, SAUTES-FRIDMAN C, SUN PD: The structure of a human Type III Fcγ receptor in complex with Fc. J. Biol. Chem. (2001) 276(19):16469-16477.
    • (2001) J. Biol. Chem. , vol.276 , Issue.19 , pp. 16469-16477
    • Radaev, S.1    Motyka, S.2    Fridman, W.H.3    Sautes-Fridman, C.4    Sun, P.D.5
  • 25
    • 1142298744 scopus 로고    scopus 로고
    • Human antibody-Fc receptor interactions illuminated by crystal structures
    • WOOF JM, BURTON DR: Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. (2004) 4 2):89-99.
    • (2004) Nat. Rev. Immunol. , vol.4 , Issue.2 , pp. 89-99
    • Woof, J.M.1    Burton, D.R.2
  • 26
    • 0032937238 scopus 로고    scopus 로고
    • Crystal structure of the human leukocyte Fc receptor, FcγRIIa
    • MAXWELL KF, POWELL MS, HULETT MD et al.: Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nat. Struct. Biol. (1999) 6(5):437-442.
    • (1999) Nat. Struct. Biol. , vol.6 , Issue.5 , pp. 437-442
    • Maxwell, K.F.1    Powell, M.S.2    Hulett, M.D.3
  • 27
    • 0033106166 scopus 로고    scopus 로고
    • Crystal structure of the soluble form ofthe human Fcγ-receptor IIb: A new member of the immunoglobulin superfamily at 1.7 A resolution
    • SONDERMANN P, HUBER R, JACOB U: Crystal structure of the soluble form ofthe human Fcγ-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution. EMBO J. (1999) 18(5):1095-1103.
    • (1999) EMBO J. , vol.18 , Issue.5 , pp. 1095-1103
    • Sondermann, P.1    Huber, R.2    Jacob, U.3
  • 28
    • 0032419721 scopus 로고    scopus 로고
    • Crystal structure ofthe human high-affinity IgE receptor
    • GARMAN SC, KINET JP, JARDETZKY TS: Crystal structure ofthe human high-affinity IgE receptor. Cell (1998) 95(7):951-961.
    • (1998) Cell , vol.95 , Issue.7 , pp. 951-961
    • Garman, S.C.1    Kinet, J.P.2    Jardetzky, T.S.3
  • 29
    • 0041344597 scopus 로고    scopus 로고
    • Crystal structure of the ectodomain of human FcαRI
    • DING Y, XU G, YANG M et al.: Crystal structure of the ectodomain of human FcαRI. J. Biol. Chem. (2003) 278 30):27966-27970.
    • (2003) J. Biol. Chem. , vol.278 , Issue.30 , pp. 27966-27970
    • Ding, Y.1    Xu, G.2    Yang, M.3
  • 30
    • 0041381311 scopus 로고    scopus 로고
    • Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor
    • WILLCOX BE, THOMAS LM, BJORKMAN PJ: Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. (2003) 4(9):913-919.
    • (2003) Nat. Immunol. , vol.4 , Issue.9 , pp. 913-919
    • Willcox, B.E.1    Thomas, L.M.2    Bjorkman, P.J.3
  • 31
    • 0033636273 scopus 로고    scopus 로고
    • Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
    • CHAPMAN TL, HEIKEMA AP, WEST AP, BJOEKMAN PJ: Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2) Immunity (2000) 13 5):727-736.
    • (2000) Immunity , vol.13 , Issue.5 , pp. 727-736
    • Chapman, T.L.1    Heikema, A.P.2    West, A.P.3    Bjoekman, P.J.4
  • 32
    • 0028239549 scopus 로고
    • Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells
    • GHAZIZADEH S, BOLEN JB, FLEIT HB: Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells. J. Biol. Chem. (1994) 269 12):8878-8884.
    • (1994) J. Biol. Chem. , vol.269 , Issue.12 , pp. 8878-8884
    • Ghazizadeh, S.1    Bolen, J.B.2    Fleit, H.B.3
  • 33
    • 0028106837 scopus 로고
    • Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn
    • WANG AV, SCHOLL PR, GEHA RS: Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn. J. Exp. Med. (1994) 180 3):1165-1170.
    • (1994) J. Exp. Med. , vol.180 , Issue.3 , pp. 1165-1170
    • Wang, A.V.1    Scholl, P.R.2    Geha, R.S.3
  • 34
    • 0032055485 scopus 로고    scopus 로고
    • SHIP modulates immune receptor responses by regulating membrane association of Btk
    • BOLLAND S, PEARSE RN, KUROSAKI T, RAVETCH JV: SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity (1998) 8(4):509-516.
    • (1998) Immunity , vol.8 , Issue.4 , pp. 509-516
    • Bolland, S.1    Pearse, R.N.2    Kurosaki, T.3    Ravetch, J.V.4
  • 35
    • 0032055476 scopus 로고    scopus 로고
    • 2+ following B-cell receptor activation
    • 2+ following B-cell receptor activation. EMBO J. (1998) 17(7):1973-1985.
    • (1998) EMBO J. , vol.17 , Issue.7 , pp. 1973-1985
    • Fluckiger, A.C.1    Li, Z.2    Kato, R.M.3
  • 36
    • 0032055484 scopus 로고    scopus 로고
    • Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals
    • SCHARENBERG AM, EL-HILLAL O, FRUMAN DA et al.: Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. (1998) 17(7):1961-1672.
    • (1998) EMBO J. , vol.17 , Issue.7 , pp. 1672-1961
    • Scharenberg, A.M.1    El-Hillal, O.2    Fruman, D.A.3
  • 37
    • 0033710778 scopus 로고    scopus 로고
    • The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells
    • TAMIR I, STOLPA JC, HELGASON CD et al.: The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity (2000) 12(3):347-358.
    • (2000) Immunity , vol.12 , Issue.3 , pp. 347-358
    • Tamir, I.1    Stolpa, J.C.2    Helgason, C.D.3
  • 38
    • 0030031886 scopus 로고    scopus 로고
    • Augmented humoral and anaphylactic responses in FcγRII-deficient mice
    • TAKAI T, ONO M, HIKIDA M, OHOMORI H, RAVETCH JV: Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature (1996) 379(6563):346-349.
    • (1996) Nature , vol.379 , Issue.6563 , pp. 346-349
    • Takai, T.1    Ono, M.2    Hikida, M.3    Ohomori, H.4    Ravetch, J.V.5
  • 40
    • 0034102982 scopus 로고    scopus 로고
    • Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility
    • JIANG Y, HIROSE S, ABE M et al.: Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics (2000) 51(6):429-435.
    • (2000) Immunogenetics , vol.51 , Issue.6 , pp. 429-435
    • Jiang, Y.1    Hirose, S.2    Abe, M.3
  • 41
    • 0037108491 scopus 로고    scopus 로고
    • Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses
    • XIU Y, NAKAMURA K, ABE M et al.: Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol. (2002) 169 8):4340-4346.
    • (2002) J. Immunol. , vol.169 , Issue.8 , pp. 4340-4346
    • Xiu, Y.1    Nakamura, K.2    Abe, M.3
  • 42
    • 0036780841 scopus 로고    scopus 로고
    • Regulation of mast-cell and basophil function and survival by IgE
    • KAWAKAMI T, GALLI SJ: Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. (2002) 2 10):773-786.
    • (2002) Nat. Rev. Immunol. , vol.2 , Issue.10 , pp. 773-786
    • Kawakami, T.1    Galli, S.J.2
  • 43
    • 1942499587 scopus 로고    scopus 로고
    • Fcγ receptors on mast cells: Activating and inhibitory regulation of mediator release
    • TRACZYK C, OKAYAMA Y, METCALFE DD, GLIFILLAN AM: Fcγ receptors on mast cells: activating and inhibitory regulation of mediator release. Int. Arch. Allergy Immunol. (2004) 133(3):305-315.
    • (2004) Int. Arch. Allergy Immunol. , vol.133 , Issue.3 , pp. 305-315
    • Traczyk, C.1    Okayama, Y.2    Metcalfe, D.D.3    Glifillan, A.M.4
  • 44
    • 0028035310 scopus 로고
    • Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation
    • PRIBLUDA VS, PRIBLUDA C, METZGER H: Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA (1994) 91(23):11246-11250.
    • (1994) Proc. Natl. Acad. Sci. USA , vol.91 , Issue.23 , pp. 11246-11250
    • Pribluda, V.S.1    Pribluda, C.2    Metzger, H.3
  • 45
  • 46
    • 0033678973 scopus 로고    scopus 로고
    • LAT is essential for FcERI-mediated mast cell activation
    • SAITOH S, ARUDCHANDRAN R, MANETZ TS et al.: LAT is essential for FcERI-mediated mast cell activation. Immunity (2000) 12(5):525-535.
    • (2000) Immunity , vol.12 , Issue.5 , pp. 525-535
    • Saitoh, S.1    Arudchandran, R.2    Manetz, T.S.3
  • 48
    • 0032238298 scopus 로고    scopus 로고
    • Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation
    • GU H, PRATT JC, BURAKOFF SJ, NEEL BG: Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol. Cell. (1998) 2(6):729-740
    • (1998) Mol. Cell. , vol.2 , Issue.6 , pp. 729-740
    • Gu, H.1    Pratt, J.C.2    Burakoff, S.J.3    Neel, B.G.4
  • 49
    • 0036347746 scopus 로고    scopus 로고
    • Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation
    • PARRAVICINI V, GADINA M, KOVAROVA M et al.: Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. (2002) 3(8):741-748.
    • (2002) Nat. Immunol. , vol.3 , Issue.8 , pp. 741-748
    • Parravicini, V.1    Gadina, M.2    Kovarova, M.3
  • 50
    • 0141483031 scopus 로고    scopus 로고
    • Role of phosphoinositide 3-kinase signaling in mast cells: New insights from knockout mouse studies
    • FUKAO T, TERAUCHI Y, KADOWAKI T, KOYASU S: Role of phosphoinositide 3-kinase signaling in mast cells: new insights from knockout mouse studies. J. Mol. Med. (2003) 81(9):524-535.
    • (2003) J. Mol. Med. , vol.81 , Issue.9 , pp. 524-535
    • Fukao, T.1    Terauchi, Y.2    Kadowaki, T.3    Koyasu, S.4
  • 51
    • 0036032969 scopus 로고    scopus 로고
    • FcERI signaling observed from the inside of the mast cell membrane
    • WILSON BS, PFEIFFER JR, OLIVER JM: FcERI signaling observed from the inside of the mast cell membrane. Mol. Immunol. (2002) 38(16-18):1259-1268.
    • (2002) Mol. Immunol. , vol.38 , Issue.16-18 , pp. 1259-1268
    • Wilson, B.S.1    Pfeiffer, J.R.2    Oliver, J.M.3
  • 52
    • 0036909507 scopus 로고    scopus 로고
    • Signal transduction during Fc receptor-mediated phagocytosis
    • GARCIA-GARCIA E, ROSALES C: Signal transduction during Fc receptor-mediated phagocytosis. J. Leukoc. Biol. (2002) 72 6):1092-1108.
    • (2002) J. Leukoc. Biol. , vol.72 , Issue.6 , pp. 1092-1108
    • Garcia-Garcia, E.1    Rosales, C.2
  • 53
    • 0035205569 scopus 로고    scopus 로고
    • Phagocytic signaling strategies: Fcγ receptor-mediated phagocytosis as a model system
    • COX D, GREENBERG S: Phagocytic signaling strategies: Fcγ receptor-mediated phagocytosis as a model system. Semin. Immunol. (2001) 13(6):339-345.
    • (2001) Semin. Immunol. , vol.13 , Issue.6 , pp. 339-345
    • Cox, D.1    Greenberg, S.2
  • 54
    • 0028042424 scopus 로고
    • FcRγ chain deletion results in pleiotrophic effector cell defects
    • TAKAI T, LI M, SYLVESTRE D, CLYNES R, RAVETCH JV: FcRγ chain deletion results in pleiotrophic effector cell defects. Cell (1994) 76(3):519-529.
    • (1994) Cell , vol.76 , Issue.3 , pp. 519-529
    • Takai, T.1    Li, M.2    Sylvestre, D.3    Clynes, R.4    Ravetch, J.V.5
  • 55
    • 0034695748 scopus 로고    scopus 로고
    • Fc receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr and Lyn
    • FITZER-ATTAS CJ, CROWLEY MT, FINN AJ, MENG F, DEFRANCO AL, LOWELL CA: Fc receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr and Lyn. J. Exp. Med. (2000) 191(4):669-682.
    • (2000) J. Exp. Med. , vol.191 , Issue.4 , pp. 669-682
    • Fitzer-Attas, C.J.1    Crowley, M.T.2    Finn, A.J.3    Meng, F.4    Defranco, A.L.5    Lowell, C.A.6
  • 56
    • 0030829551 scopus 로고    scopus 로고
    • A critical role for Syk in signal transduction and phagocytosis mediated by Fc receptors on macrophages
    • CROWLEY MT, COSTELLO PS, FITZER-ATTAS CJ et al.: A critical role for Syk in signal transduction and phagocytosis mediated by Fc receptors on macrophages. J. Exp. Med. (1997) 186 7):1027-1039.
    • (1997) J. Exp. Med. , vol.186 , Issue.7 , pp. 1027-1039
    • Crowley, M.T.1    Costello, P.S.2    Fitzer-Attas, C.J.3
  • 57
    • 0031807018 scopus 로고    scopus 로고
    • The Syk protein tyrosine kinase is essential for Fc receptor signaling in macrophages and neutrophils
    • KIEFER F, BRUMELL J, AL-ALAWII N et al.: The Syk protein tyrosine kinase is essential for Fc receptor signaling in macrophages and neutrophils. Mol. Cell Biol. (1998) 18 7):4209-4220.
    • (1998) Mol. Cell Biol. , vol.18 , Issue.7 , pp. 4209-4220
    • Kiefer, F.1    Brumell, J.2    Al-Alawii, N.3
  • 58
    • 0033068059 scopus 로고    scopus 로고
    • Protein kinase C and a calcium-independent phospholipase are required for IgG-mediated phagocytosis by Mono-Mac-6 cells
    • KARIMI K, GEMMILL TR, LENNARTZ MR: Protein kinase C and a calcium-independent phospholipase are required for IgG-mediated phagocytosis by Mono-Mac-6 cells. J. Leukoc. Biol. (1999) 65 6):854-862.
    • (1999) J. Leukoc. Biol. , vol.65 , Issue.6 , pp. 854-862
    • Karimi, K.1    Gemmill, T.R.2    Lennartz, M.R.3
  • 59
    • 0034710805 scopus 로고    scopus 로고
    • Protein kinase C-α participates in FcγR-mediated phagocytosis in macrophages
    • BRETON A, DESCOTEAUX A: Protein kinase C-α participates in FcγR-mediated phagocytosis in macrophages. Biochem. Biophys. Res. Commun. (2000) 276(2):472-476.
    • (2000) Biochem. Biophys. Res. Commun. , vol.276 , Issue.2 , pp. 472-476
    • Breton, A.1    Descoteaux, A.2
  • 60
    • 0034725039 scopus 로고    scopus 로고
    • The requirement of both extracellular regulated kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A(2) activity by either FcγRIIA or FcγRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex
    • HAZAN-HALEVY I, SWGER R, LEVY R: The requirement of both extracellular regulated kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A(2) activity by either FcγRIIA or FcγRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex. J. Biol. Chem. (2000) 275 17):12416-12423.
    • (2000) J. Biol. Chem. , vol.275 , Issue.17 , pp. 12416-12423
    • Hazan-Halevy, I.1    Swger, R.2    Levy, R.3
  • 61
    • 0034739859 scopus 로고    scopus 로고
    • Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis
    • BOTELHO RJ, TERUEL M, DIERCKMAN R et al.: Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell. Biol. (2000) 151(7):1353-1368.
    • (2000) J. Cell. Biol. , vol.151 , Issue.7 , pp. 1353-1368
    • Botelho, R.J.1    Teruel, M.2    Dierckman, R.3
  • 62
    • 0033558080 scopus 로고    scopus 로고
    • Fcγ receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles
    • KUSNER DJ, HALL CF, JACKSON S: Fcγ receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles. J. Immunol. (1999) 162(4):2266-2274.
    • (1999) J. Immunol. , vol.162 , Issue.4 , pp. 2266-2274
    • Kusner, D.J.1    Hall, C.F.2    Jackson, S.3
  • 63
    • 0141532180 scopus 로고    scopus 로고
    • Class I phosphoinositide 3-kinase p110β is required for apoptotic cell and Fcγ receptor-mediated phagocytosis by macrophages
    • LEVERRIER Y, OKKENHAUG K, SAWYER C, BILANCIO A, VANHAESEBROECK B, RIDLEY AJ: Class I phosphoinositide 3-kinase p110β is required for apoptotic cell and Fcγ receptor-mediated phagocytosis by macrophages. J. Biol. Chem. (2003) 278(40):38437-38442.
    • (2003) J. Biol. Chem. , vol.278 , Issue.40 , pp. 38437-38442
    • Leverrier, Y.1    Okkenhaug, K.2    Sawyer, C.3    Bilancio, A.4    Vanhaesebroeck, B.5    Ridley, A.J.6
  • 64
    • 2642518949 scopus 로고    scopus 로고
    • Fcγ receptor signaling in primary human microglia: Differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction
    • SONG X, TANAKA S, COX D, LEE SC: Fcγ receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J. Leukoc. Biol. (2004) 75(6):1147-1155.
    • (2004) J. Leukoc. Biol. , vol.75 , Issue.6 , pp. 1147-1155
    • Song, X.1    Tanaka, S.2    Cox, D.3    Lee, S.C.4
  • 66
    • 0029026704 scopus 로고
    • 2+ accumulation in Fcγ-receptor-mediated phagocytosis of human neutrophils
    • 2+ accumulation in Fcγ-receptor-mediated phagocytosis of human neutrophils. J. Biochem. (1995) 117 6):1156-1161.
    • (1995) J. Biochem. , vol.117 , Issue.6 , pp. 1156-1161
    • Kobayashi, K.1    Takahashi, K.2    Nagasawa, S.3
  • 67
    • 0034306013 scopus 로고    scopus 로고
    • Function of Rho family proteins in actin dynamics during phagocytosis and engulfment
    • CHIMINI G, CHAVRIER P: Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat. Cell. Biol. (2000) 2(10):E191-E196.
    • (2000) Nat. Cell. Biol. , vol.2 , Issue.10
    • Chimini, G.1    Chavrier, P.2
  • 68
    • 0036175145 scopus 로고    scopus 로고
    • Dynamics of cytoskeletal proteins during Fcγ receptor-mediated phagocytosis in macrophages
    • DIAKONOVA M, BOKOCH G, SWANSON JA: Dynamics of cytoskeletal proteins during Fcγ receptor-mediated phagocytosis in macrophages. Mol. Biol. Cell. (2002) 13(2):402-411.
    • (2002) Mol. Biol. Cell. , vol.13 , Issue.2 , pp. 402-411
    • Diakonova, M.1    Bokoch, G.2    Swanson, J.A.3
  • 69
    • 0035954430 scopus 로고    scopus 로고
    • Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis
    • MARSHALL JG, BOOTH JW, STAMBOLIC V et al.: Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis. J. Cell. Biol. (2001) 153(7):1369-1380.
    • (2001) J. Cell. Biol. , vol.153 , Issue.7 , pp. 1369-1380
    • Marshall, J.G.1    Booth, J.W.2    Stambolic, V.3
  • 70
    • 0035494493 scopus 로고    scopus 로고
    • Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation
    • VIEIRA OV, BOTELHO RJ, RAMEH L et al.: Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J. Cell. Biol. (2001) 155(1):19-25.
    • (2001) J. Cell. Biol. , vol.155 , Issue.1 , pp. 19-25
    • Vieira, O.V.1    Botelho, R.J.2    Rameh, L.3
  • 71
    • 0038491474 scopus 로고    scopus 로고
    • Critical role for scaffolding adapter Gab2 in FcγR-mediated phagocytosis
    • GU H, BOTELHO RJ, YU M, GRINSTEIN S, NEEL BG: Critical role for scaffolding adapter Gab2 in FcγR-mediated phagocytosis. J. Cell. Biol. (2003) 161(6):1151-1161.
    • (2003) J. Cell. Biol. , vol.161 , Issue.6 , pp. 1151-1161
    • Gu, H.1    Botelho, R.J.2    Yu, M.3    Grinstein, S.4    Neel, B.G.5
  • 72
    • 0142151094 scopus 로고    scopus 로고
    • The inhibitory receptor FcγRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcγRI/III but also by efficient clearance and endocytosis of immune complexes
    • VAN LENT P, NABBE KC, BOROSS P et al.: The inhibitory receptor FcγRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcγRI/III but also by efficient clearance and endocytosis of immune complexes. Am. J. Pathol. (2003) 163(5):1839-1848.
    • (2003) Am. J. Pathol. , vol.163 , Issue.5 , pp. 1839-1848
    • Van Lent, P.1    Nabbe, K.C.2    Boross, P.3
  • 73
    • 0028786994 scopus 로고
    • Implicating a role for immune recognition of self in tumor rejection: Passive immunization against the brown locus protein
    • HARA I, TAKECHI Y, HOUGHTON AN: Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med. (1995) 182(5):1609-1614.
    • (1995) J. Exp. Med. , vol.182 , Issue.5 , pp. 1609-1614
    • Hara, I.1    Takechi, Y.2    Houghton, A.N.3
  • 75
    • 0034076307 scopus 로고    scopus 로고
    • Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    • CLYNES RA, TOWERS TL, PRESTA LG, RAVETCH JV: Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. (2000) 6(4): 443-446.
    • (2000) Nat. Med. , vol.6 , Issue.4 , pp. 443-446
    • Clynes, R.A.1    Towers, T.L.2    Presta, L.G.3    Ravetch, J.V.4
  • 76
    • 10744220151 scopus 로고    scopus 로고
    • Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
    • TAKEDA K, YAMAGUCHI N, AKIBA H et al.: Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy J. Exp. Med. (2004) 199(4):437-448.
    • (2004) J. Exp. Med. , vol.199 , Issue.4 , pp. 437-448
    • Takeda, K.1    Yamaguchi, N.2    Akiba, H.3
  • 77
    • 0037442125 scopus 로고    scopus 로고
    • Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells
    • AKIYAMA K, EBIHARA S, YAD A et al.: Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells. J. Immunol. (2003) 170 4):1641-1648.
    • (2003) J. Immunol. , vol.170 , Issue.4 , pp. 1641-1648
    • Akiyama, K.1    Ebihara, S.2    Yad, A.3
  • 78
    • 0345414168 scopus 로고    scopus 로고
    • Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake
    • YADA A, EBIHARA S, MATSUMURA K et al.: Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake. Cell. Immunol. (2003) 225(1):21-32.
    • (2003) Cell. Immunol. , vol.225 , Issue.1 , pp. 21-32
    • Yada, A.1    Ebihara, S.2    Matsumura, K.3
  • 79
    • 0033579698 scopus 로고    scopus 로고
    • Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
    • REGNAULT A, LANKAR D, LACABANNE V et al.: Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. (1999) 189 2):371-380.
    • (1999) J. Exp. Med. , vol.189 , Issue.2 , pp. 371-380
    • Regnault, A.1    Lankar, D.2    Lacabanne, V.3
  • 80
    • 0033203120 scopus 로고    scopus 로고
    • Selective transport of internalized antigens to the cyrosol for MHC class I presentation in dendritic cells
    • RODRIGUEZ A, REGNAULT A, KLEIJMEER M, RICCIARDI-CASTAGNOLI P, AMIGORENA S: Selective transport of internalized antigens to the cyrosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. (1999) 1(6):362-368.
    • (1999) Nat. Cell. Biol. , vol.1 , Issue.6 , pp. 362-368
    • Rodriguez, A.1    Regnault, A.2    Kleijmeer, M.3    Ricciardi-Castagnoli, P.4    Amigorena, S.5
  • 81
    • 0037033448 scopus 로고    scopus 로고
    • Antitumor monoclonal antibodies enhance cross-presentation of cCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells
    • DHODAPKAR KM, KRASOVSKY J, WILLIAMSON B, DHODAPKAR MV: Antitumor monoclonal antibodies enhance cross-presentation of cCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. (2002) 195(1):125-133.
    • (2002) J. Exp. Med. , vol.195 , Issue.1 , pp. 125-133
    • Dhodapkar, K.M.1    Krasovsky, J.2    Williamson, B.3    Dhodapkar, M.V.4
  • 82
    • 0037124367 scopus 로고    scopus 로고
    • Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells
    • KALERGIS AM, RAVETCH JV: Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. (2002) 195(12):1653-1659.
    • (2002) J. Exp. Med. , vol.195 , Issue.12 , pp. 1653-1659
    • Kalergis, A.M.1    Ravetch, J.V.2
  • 83
    • 0037089544 scopus 로고    scopus 로고
    • Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells
    • ZUM BUSCHENFELDE CM, HERMANN C, SCHMIDT B, PESCHEL C, BERNHARD H: Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells. Cancer Res. (2002) 62(8):2244-2247.
    • (2002) Cancer Res. , vol.62 , Issue.8 , pp. 2244-2247
    • Zum Buschenfelde, C.M.1    Hermann, C.2    Schmidt, B.3    Peschel, C.4    Bernhard, H.5
  • 84
    • 0021241263 scopus 로고
    • The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains
    • MOSTOV KE, FRIEDLANDER M, BLOBEL G: The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature (1984) 308(5954):37-43.
    • (1984) Nature , vol.308 , Issue.5954 , pp. 37-43
    • Mostov, K.E.1    Friedlander, M.2    Blobel, G.3
  • 85
    • 0035920589 scopus 로고    scopus 로고
    • Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy
    • MOURA IC, CENTELLES MN, ARCOS-FAJARDO M et al.: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. (2001) 194(4):417-425.
    • (2001) J. Exp. Med. , vol.194 , Issue.4 , pp. 417-425
    • Moura, I.C.1    Centelles, M.N.2    Arcos-Fajardo, M.3
  • 86
    • 0037084066 scopus 로고    scopus 로고
    • IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution
    • RAMALINGAM TS, DETMER SA, MARTIN WL, BJORKMAN PJ: IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution. EMBO J. (2002) 21(4):590-601.
    • (2002) EMBO J. , vol.21 , Issue.4 , pp. 590-601
    • Ramalingam, T.S.1    Detmer, S.A.2    Martin, W.L.3    Bjorkman, P.J.4
  • 87
    • 2942516894 scopus 로고    scopus 로고
    • Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells
    • YOSHIDA M, CLAYPOOL SM, WAGNER JS et al.: Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity (2004) 20(6):769-783.
    • (2004) Immunity , vol.20 , Issue.6 , pp. 769-783
    • Yoshida, M.1    Claypool, S.M.2    Wagner, J.S.3
  • 88
    • 0033679212 scopus 로고    scopus 로고
    • A second amplifier function for the allergy-associated FcERI-β subunit
    • DONNADIEU E, JOUVIN MH, KINET JP: A second amplifier function for the allergy-associated FcERI-β subunit. Immunity (2000) 12 5):515-523.
    • (2000) Immunity , vol.12 , Issue.5 , pp. 515-523
    • Donnadieu, E.1    Jouvin, M.H.2    Kinet, J.P.3
  • 89
    • 0038742799 scopus 로고    scopus 로고
    • Competing functions encoded in the allergy-associated FcERIβ gene
    • DONNADIEU E, JOUVIN MH, RANA S et al.: Competing functions encoded in the allergy-associated FcERIβ gene. Immunity (2003) 18(5):665-674.
    • (2003) Immunity , vol.18 , Issue.5 , pp. 665-674
    • Donnadieu, E.1    Jouvin, M.H.2    Rana, S.3
  • 90
    • 0034895245 scopus 로고    scopus 로고
    • Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family
    • TAKAI T, ONO M: Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol. Rev. (2001) 181:215-222.
    • (2001) Immunol. Rev. , vol.181 , pp. 215-222
    • Takai, T.1    Ono, M.2
  • 91
    • 0027729893 scopus 로고
    • Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene
    • DOMBROWICZ D, FLAMAND V, BRIGMAN KK, KOLLER BH, KINET JP: Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell (1993) 75 5):969-976.
    • (1993) Cell , vol.75 , Issue.5 , pp. 969-976
    • Dombrowicz, D.1    Flamand, V.2    Brigman, K.K.3    Koller, B.H.4    Kinet, J.P.5
  • 92
    • 0030615040 scopus 로고    scopus 로고
    • Absence of FcERIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcERI and FcγRIII for limiting amounts of FcRβ and γ chains
    • DOMBROWICZ D, FLAMAND V, MIYAJIMA I, RAVETCH JV, GALLI SJ, KINET JP: Absence of FcERIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcERI and FcγRIII for limiting amounts of FcRβ and γ chains. J. Clin. Invest. (1997) 99(5):915-925.
    • (1997) J. Clin. Invest. , vol.99 , Issue.5 , pp. 915-925
    • Dombrowicz, D.1    Flamand, V.2    Miyajima, I.3    Ravetch, J.V.4    Galli, S.J.5    Kinet, J.P.6
  • 93
    • 0033577901 scopus 로고    scopus 로고
    • Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG
    • UJIKE A, ISHIKAWA Y, ONO M et al.: Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. (1999) 189(10):1573-1579.
    • (1999) J. Exp. Med. , vol.189 , Issue.10 , pp. 1573-1579
    • Ujike, A.1    Ishikawa, Y.2    Ono, M.3
  • 94
    • 18344370440 scopus 로고    scopus 로고
    • FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection
    • IOAN-FACSINAY A, DE KIMPE SJ, HELLWIG SM et al.: FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 16(3):391-402.
    • (2002) Immunity , vol.16 , Issue.3 , pp. 391-402
    • Ioan-Facsinay, A.1    De Kimpe, S.J.2    Hellwig, S.M.3
  • 95
    • 0028222926 scopus 로고
    • Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development
    • STIEF A, TEXIDO G, SANSIG G, EIBEL H, LE GROS G, VAN DER PUTTEN H: Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J. Immunol. (1994) 152(7):3378-3390.
    • (1994) J. Immunol. , vol.152 , Issue.7 , pp. 3378-3390
    • Stief, A.1    Texido, G.2    Sansig, G.3    Eibel, H.4    Le Gros, G.5    Van Der Putten, H.6
  • 96
    • 0028284181 scopus 로고
    • Negative feedback regulation of IgE synthesis by murine CD23
    • YU P, KOSCO-VILBOIS M, RICHARDS M, KOHLER G, LAMERS MC: Negative feedback regulation of IgE synthesis by murine CD23. Nature (1994) 369(6483):753-756.
    • (1994) Nature , vol.369 , Issue.6483 , pp. 753-756
    • Yu, P.1    Kosco-Vilbois, M.2    Richards, M.3    Kohler, G.4    Lamers, M.C.5
  • 97
    • 0028108063 scopus 로고
    • Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses
    • TEXIDO G, EIBEL H, LE GROS G, VAN DER PUTTEN H: Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J. Immunol. (1994) 153(7):3028-3042.
    • (1994) J. Immunol. , vol.153 , Issue.7 , pp. 3028-3042
    • Texido, G.1    Eibel, H.2    Le Gros, G.3    Van Der Putten, H.4
  • 98
    • 0035753991 scopus 로고    scopus 로고
    • Autoreactivity by design: Innate B and T lymphocytes
    • BENDELAC A, BONNEVILLE M, KEARNEY JF: Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. (2001) 1 3):177-186.
    • (2001) Nat. Rev. Immunol. , vol.1 , Issue.3 , pp. 177-186
    • Bendelac, A.1    Bonneville, M.2    Kearney, J.F.3
  • 99
    • 0034192427 scopus 로고    scopus 로고
    • Induction and suppression of collagen-induced arthritis is dependent on distinct Fc receptors
    • KLEINAU S, MARTINSSON P, HEYMAN B: Induction and suppression of collagen-induced arthritis is dependent on distinct Fc receptors. J. Exp. Med. (2000) 191(9):1611-1616.
    • (2000) J. Exp. Med. , vol.191 , Issue.9 , pp. 1611-1616
    • Kleinau, S.1    Martinsson, P.2    Heyman, B.3
  • 100
    • 0037725010 scopus 로고    scopus 로고
    • Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcγRIIB-deficient mice
    • NAKAMURA A, NUKIWA T, TAKAI T: Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcγRIIB-deficient mice. J. Autoimmun. (2003) 20(3):227-236.
    • (2003) J. Autoimmun. , vol.20 , Issue.3 , pp. 227-236
    • Nakamura, A.1    Nukiwa, T.2    Takai, T.3
  • 101
    • 17944384552 scopus 로고    scopus 로고
    • Resistance of Fc receptor-deficient mice to fatal glomerulonephritis
    • PARK SY, UEDA S, OHNO H et al.: Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. (1998) 102(6):1229-1238.
    • (1998) J. Clin. Invest. , vol.102 , Issue.6 , pp. 1229-1238
    • Park, S.Y.1    Ueda, S.2    Ohno, H.3
  • 102
    • 0034002678 scopus 로고    scopus 로고
    • Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRγ-deficient mice
    • WAKAYAMA H, HASEGAWA Y, KAWABE T et al.: Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRγ-deficient mice. Eur. J. Immunol. (2000) 30 4):1182-1190.
    • (2000) Eur. J. Immunol. , vol.30 , Issue.4 , pp. 1182-1190
    • Wakayama, H.1    Hasegawa, Y.2    Kawabe, T.3
  • 103
    • 0032512855 scopus 로고    scopus 로고
    • Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
    • CLYNES R, DUMITRU C, RAVETCH JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science (1998) 279(5353):1052-1054.
    • (1998) Science , vol.279 , Issue.5353 , pp. 1052-1054
    • Clynes, R.1    Dumitru, C.2    Ravetch, J.V.3
  • 104
    • 18344365948 scopus 로고    scopus 로고
    • Arthritis critically dependent on innate immune system players
    • JI H, OHMURA K, MALHMOOD U et al.: Arthritis critically dependent on innate immune system players. Immunity (2002) 16 2):157-168.
    • (2002) Immunity , vol.16 , Issue.2 , pp. 157-168
    • Ji, H.1    Ohmura, K.2    Malhmood, U.3
  • 105
    • 0037446774 scopus 로고    scopus 로고
    • Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis
    • KAGARI T, TANAKA D, DOI H, SHIMOZATO T: Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J. Immunol. (2003) 170(8):4318-4324.
    • (2003) J. Immunol. , vol.170 , Issue.8 , pp. 4318-4324
    • Kagari, T.1    Tanaka, D.2    Doi, H.3    Shimozato, T.4
  • 106
    • 0037089664 scopus 로고    scopus 로고
    • Arthritogenic monoclonal antibodies from K/BxN mice
    • MACCIONI M, ZEDER-LUTZ G, HUANG H et al.: Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. (2002) 195 8):1071-1077.
    • (2002) J. Exp. Med. , vol.195 , Issue.8 , pp. 1071-1077
    • Maccioni, M.1    Zeder-Lutz, G.2    Huang, H.3
  • 107
    • 0036771572 scopus 로고    scopus 로고
    • Expression of FcγRIII is required for development of collagen-induced arthritis
    • DIAZ DE STAHL T, ANDREN M, MARTINSSON P, VERBEEK JS, KLEINAU S: Expression of FcγRIII is required for development of collagen-induced arthritis. Eur. J. Immunol. (2002) 32(10):2915-2922.
    • (2002) Eur. J. Immunol. , vol.32 , Issue.10 , pp. 2915-2922
    • Diaz De Stahl, T.1    Andren, M.2    Martinsson, P.3    Verbeek, J.S.4    Kleinau, S.5
  • 108
    • 0032217049 scopus 로고    scopus 로고
    • FcγRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia
    • MEYER D, SCHILLER C, WESTEMANN J et al.: FcγRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood (1998) 92 11):3997-4002.
    • (1998) Blood , vol.92 , Issue.11 , pp. 3997-4002
    • Meyer, D.1    Schiller, C.2    Westemann, J.3
  • 109
    • 0031702690 scopus 로고    scopus 로고
    • Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis
    • SUZUKI Y, SHIRATO I, OKUMURA K et al.: Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. (1998) 54 4):1166-1174.
    • (1998) Kidney Int. , vol.54 , Issue.4 , pp. 1166-1174
    • Suzuki, Y.1    Shirato, I.2    Okumura, K.3
  • 110
    • 0033521604 scopus 로고    scopus 로고
    • Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors
    • CLYNES R, MAIZES JS, GUINAMARD R, ONO M, TAKAI T, RAVETCH JV: Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. (1999) 189(1):179-185.
    • (1999) J. Exp. Med. , vol.189 , Issue.1 , pp. 179-185
    • Clynes, R.1    Maizes, J.S.2    Guinamard, R.3    Ono, M.4    Takai, T.5    Ravetch, J.V.6
  • 111
    • 0034610854 scopus 로고    scopus 로고
    • Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with Type IV collagen: A novel murine model for autoimmune glomerular basement membrane disease
    • NAKAMURA A, YUASA T, UJIKE A et al.: Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with Type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. (2000) 191(5):899-906.
    • (2000) J. Exp. Med. , vol.191 , Issue.5 , pp. 899-906
    • Nakamura, A.1    Yuasa, T.2    Ujike, A.3
  • 112
    • 0018830639 scopus 로고
    • Immunization against heterologous Type II collagen induces arthritis in mice
    • COURTENAY JS, DALLMAN MJ, DAYAN AD, MARTIN A, MOSEDALE B: Immunization against heterologous Type II collagen induces arthritis in mice. Nature (1980) 283(5748):666-668.
    • (1980) Nature , vol.283 , Issue.5748 , pp. 666-668
    • Courtenay, J.S.1    Dallman, M.J.2    Dayan, A.D.3    Martin, A.4    Mosedale, B.5
  • 113
    • 0017657009 scopus 로고
    • Autoimmunity to Type II collagen an experimental model of arthritis
    • TRENTHAM DE, TOWNES AS, KANG AH: Autoimmunity to Type II collagen an experimental model of arthritis. J. Exp. Med. (1977) 146(3):857-868.
    • (1977) J. Exp. Med. , vol.146 , Issue.3 , pp. 857-868
    • Trentham, D.E.1    Townes, A.S.2    Kang, A.H.3
  • 114
    • 0019512029 scopus 로고
    • Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates
    • WOOLEY PH, LUTHRA HS, STIART JM, DAVID CS: Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates. J. Exp. Med. (1981) 154 3):688-700.
    • (1981) J. Exp. Med. , vol.154 , Issue.3 , pp. 688-700
    • Wooley, P.H.1    Luthra, H.S.2    Stiart, J.M.3    David, C.S.4
  • 115
    • 0033521239 scopus 로고    scopus 로고
    • Deletion of Fcγ receptor IIB renders H-2b mice susceptible to collagen-induced arthritis
    • YUASA T, KUBO S, YOSHINO T et al.: Deletion of Fcγ receptor IIB renders H-2b mice susceptible to collagen-induced arthritis. J. Exp. Med. (1999) 189(1):187-194.
    • (1999) J. Exp. Med. , vol.189 , Issue.1 , pp. 187-194
    • Yuasa, T.1    Kubo, S.2    Yoshino, T.3
  • 116
    • 0033695963 scopus 로고    scopus 로고
    • Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
    • BOLLAND S, RAVETCH JV: Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity (2000) 13(2):277-285.
    • (2000) Immunity , vol.13 , Issue.2 , pp. 277-285
    • Bolland, S.1    Ravetch, J.V.2
  • 117
    • 0034816964 scopus 로고    scopus 로고
    • Delineating the genetic basis of systemic lupus erythematosus
    • WAKELAND EK, LIU K, GRAHAM RR, BEHRENS TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity (2001) 15(3):397-408.
    • (2001) Immunity , vol.15 , Issue.3 , pp. 397-408
    • Wakeland, E.K.1    Liu, K.2    Graham, R.R.3    Behrens, T.W.4
  • 118
    • 0021948204 scopus 로고
    • Interaction of mutant lpr gene with background strain influences renal disease
    • KELLY VE, ROTHS JB: Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. (1985) 37(2):220-229.
    • (1985) Clin. Immunol. Immunopathol. , vol.37 , Issue.2 , pp. 220-229
    • Kelly, V.E.1    Roths, J.B.2
  • 119
    • 0018072901 scopus 로고
    • Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
    • ANDREWS BS, EISENBERG RA, THEOFILOPOULOS AN et al.: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. (1978) 148 5):1198-1215.
    • (1978) J. Exp. Med. , vol.148 , Issue.5 , pp. 1198-1215
    • Andrews, B.S.1    Eisenberg, R.A.2    Theofilopoulos, A.N.3
  • 120
    • 0037730377 scopus 로고    scopus 로고
    • FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease
    • YAJIMA K, NAKAMURA A, SUGAHARA A, TAKAI T: FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Eur. J. Immunol. (2003) 33 4):1020-1029.
    • (2003) Eur. J. Immunol. , vol.33 , Issue.4 , pp. 1020-1029
    • Yajima, K.1    Nakamura, A.2    Sugahara, A.3    Takai, T.4
  • 121
    • 0035057371 scopus 로고    scopus 로고
    • Fc-signalling in the modulation of immune responses by passive antibody
    • SINCLAIR NR: Fc-signalling in the modulation of immune responses by passive antibody. Scand. J. Immunol. (2001) 53 4):322-330.
    • (2001) Scand. J. Immunol. , vol.53 , Issue.4 , pp. 322-330
    • Sinclair, N.R.1
  • 122
    • 2342424834 scopus 로고    scopus 로고
    • Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer
    • TAKAI T, NAKAMURA A, AKIYAMA K: Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer. Curr. Drug. Targets. Immune. Endocr. Metabol. Disord. (2003) 3 3):187-197.
    • (2003) Curr. Drug Targets Immune Endocr. Metabol. Disord. , vol.3 , Issue.3 , pp. 187-197
    • Takai, T.1    Nakamura, A.2    Akiyama, K.3
  • 123
    • 0032705171 scopus 로고    scopus 로고
    • Atopic allergy and other hypersensitivities
    • KINET JP: Atopic allergy and other hypersensitivities. Curr. Opin. Immunol. (1999) 11(6):603-605.
    • (1999) Curr. Opin. Immunol. , vol.11 , Issue.6 , pp. 603-605
    • Kinet, J.P.1
  • 124
    • 1342287014 scopus 로고    scopus 로고
    • Innovative therapies for asthma: Anti-IgE - The future?
    • WEINBERGER M: Innovative therapies for asthma: anti-IgE - the future? Paediatr. Respir. Rev. (2004) 5(Suppl. A):S115-S118.
    • (2004) Paediatr. Respir. Rev. , vol.5 , Issue.SUPPL. A
    • Weinberger, M.1
  • 125
    • 0035262324 scopus 로고    scopus 로고
    • Anti-immunoglobulin E for the treatment of allergic disease
    • BUSSE W, NEAVILLE W: Anti-immunoglobulin E for the treatment of allergic disease. Curr. Opin. Allergy. Clin. Immunol. (2001) 1(1):105-108.
    • (2001) Curr. Opin. Allergy Clin. Immunol. , vol.1 , Issue.1 , pp. 105-108
    • Busse, W.1    Neaville, W.2
  • 126
    • 0842348085 scopus 로고    scopus 로고
    • Anti-cytokine Ab immune therapy: Present status and perspectives
    • ZAGURY D, GALLO RC: Anti-cytokine Ab immune therapy: present status and perspectives. Drug Discov. Today (2004) 9 2):72-81.
    • (2004) Drug Discov. Today , vol.9 , Issue.2 , pp. 72-81
    • Zagury, D.1    Gallo, R.C.2
  • 127
    • 0036883552 scopus 로고    scopus 로고
    • Molecular aspects of allergy
    • MIESCHER SM, VOGEL M: Molecular aspects of allergy. Mol. Aspects Med. (2002) 23(6):413-462.
    • (2002) Mol. Aspects Med. , vol.23 , Issue.6 , pp. 413-462
    • Miescher, S.M.1    Vogel, M.2
  • 128
    • 0035973343 scopus 로고    scopus 로고
    • Pathways for self-tolerance and the treatment of autoimmune diseases
    • GOODNOW CC: Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet (2001) 357(9274):2115-2121.
    • (2001) Lancet , vol.357 , Issue.9274 , pp. 2115-2121
    • Goodnow, C.C.1
  • 129
    • 2342523339 scopus 로고    scopus 로고
    • Autoantibodies as predictors of disease
    • SCOFIELD RH: Autoantibodies as predictors of disease. Lancet (2004) 363(9420):1544-1546.
    • (2004) Lancet , vol.363 , Issue.9420 , pp. 1544-1546
    • Scofield, R.H.1
  • 130
    • 2442590862 scopus 로고    scopus 로고
    • New drugs for rheumatoid arthritis
    • OLSENI NJ, STEIN CM: New drugs for rheumatoid arthritis. N. Engl. J. Med. (2004) 350(21):2167-2179.
    • (2004) N. Engl. J. Med. , vol.350 , Issue.21 , pp. 2167-2179
    • Olseni, N.J.1    Stein, C.M.2
  • 132
    • 0035056003 scopus 로고    scopus 로고
    • Anti-TNF-α therapy of rheumatoid arthritis: What have we learned?
    • FELDMANN M, MAINI RN: Anti-TNF-α therapy of rheumatoid arthritis: what have we learned? Ann. Rev. Immunol. (2001) 19 163-196.
    • (2001) Ann. Rev. Immunol. , vol.19 , pp. 163-196
    • Feldmann, M.1    Maini, R.N.2
  • 133
    • 0029617952 scopus 로고
    • Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist
    • BUTLER DM, MAINI RN, FELDMANN M, BRENNAN FM: Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist. Eur. Cytokine. Netw. (1995) 6 4):225-230.
    • (1995) Eur. Cytokine Netw. , vol.6 , Issue.4 , pp. 225-230
    • Butler, D.M.1    Maini, R.N.2    Feldmann, M.3    Brennan, F.M.4
  • 134
    • 0036899812 scopus 로고    scopus 로고
    • Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial
    • CHOY EH, ISENBERG DA, GARROOD T et al.: Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis. Rheum. (2002) 46(12):3143-3150.
    • (2002) Arthritis Rheum. , vol.46 , Issue.12 , pp. 3143-3150
    • Choy, E.H.1    Isenberg, D.A.2    Garrood, T.3
  • 135
    • 2642558925 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial
    • NISHIMOTO N, YOSHIZAKI K, MIYASAKA N et al.: Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis. Rheum. (2004) 50(6):1761-1769.
    • (2004) Arthritis Rheum. , vol.50 , Issue.6 , pp. 1761-1769
    • Nishimoto, N.1    Yoshizaki, K.2    Miyasaka, N.3
  • 137
    • 0029862164 scopus 로고    scopus 로고
    • Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
    • KOSHY M, BERGER D, CROW MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. (1996) 98(3):826-837.
    • (1996) J. Clin. Invest. , vol.98 , Issue.3 , pp. 826-837
    • Koshy, M.1    Berger, D.2    Crow, M.K.3
  • 138
    • 0029913381 scopus 로고    scopus 로고
    • Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
    • DESAI-MEHTA A, LU L, RAMSEY-GOLDMANOL R, DATTA SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. (1996) 97(9):2063-2073.
    • (1996) J. Clin. Invest. , vol.97 , Issue.9 , pp. 2063-2073
    • Desai-Mehta, A.1    Lu, L.2    Ramsey-Goldmanol, R.3    Datta, S.K.4
  • 139
    • 0032742987 scopus 로고    scopus 로고
    • The soluble CD40 ligand sCD154 in systemic lupus erythematosus
    • KATO K, SANTANA-SAHAGÚN E, RASSENTI L Z et al.: The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J. Clin. Invest. (1999) 104(7):947-955.
    • (1999) J. Clin. Invest. , vol.104 , Issue.7 , pp. 947-955
    • Kato, K.1    Santana-Sahagún, E.2    Rassenti, L.Z.3
  • 140
    • 0345824714 scopus 로고    scopus 로고
    • Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions
    • GRAMMER AC, SLOTA R, FISHER R et al.: Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. (2003) 112 10):1506-1520.
    • (2003) J. Clin. Invest. , vol.112 , Issue.10 , pp. 1506-1520
    • Grammer, A.C.1    Slota, R.2    Fisher, R.3
  • 141
    • 0036899589 scopus 로고    scopus 로고
    • Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD 154: A randomized, double-blind, placebo-controlled trial
    • IDEC-131 Lupus Study Group
    • KALUNIAN KC, DAVIS JC Jr, MERRILL JT, TOTORITIS MC, WOFSY D: IDEC-131 Lupus Study Group. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD 154: a randomized, double-blind, placebo-controlled trial. Arthritis. Rheum. (2002) 46(12):3251-3258.
    • (2002) Arthritis Rheum. , vol.4 , Issue.612 , pp. 3251-3258
    • Kalunian, K.C.1    Davis Jr., J.C.2    Merrill, J.T.3    Totoritis, M.C.4    Wofsy, D.5
  • 142
    • 0033965079 scopus 로고    scopus 로고
    • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
    • KAWAI T, ANDREWS D, COLVIN RB, SACHS DH, COSIMI AB: Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med. (2000) 6(2):114.
    • (2000) Nat. Med. , vol.6 , Issue.2 , pp. 114
    • Kawai, T.1    Andrews, D.2    Colvin, R.B.3    Sachs, D.H.4    Cosimi, A.B.5
  • 145
    • 2942537697 scopus 로고    scopus 로고
    • Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    • EDWARDS JC, SZCZEPANSKI L, SZECHINSKI J et al.: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. (2004) 350 25):2572-2581.
    • (2004) N. Engl. J. Med. , vol.350 , Issue.25 , pp. 2572-2581
    • Edwards, J.C.1    Szczepanski, L.2    Szechinski, J.3
  • 146
    • 0033230622 scopus 로고    scopus 로고
    • Clinical applications of anti-CD20 antibodies
    • GOPAL AK, PRESS OW. Clinical applications of anti-CD20 antibodies. J. Lab. Clin. Med. (1999) 134(5):445-450.
    • (1999) J. Lab. Clin. Med. , vol.134 , Issue.5 , pp. 445-450
    • Gopal, A.K.1    Press, O.W.2
  • 147
    • 3042592452 scopus 로고    scopus 로고
    • The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
    • UCHIDA J, HAMAGUCHI Y, OLIVER JA et al.: The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. (2004) 199(12):1659-6169.
    • (2004) J. Exp. Med. , vol.199 , Issue.12 , pp. 1659-6169
    • Uchida, J.1    Hamaguchi, Y.2    Oliver, J.A.3
  • 148
    • 0037289807 scopus 로고    scopus 로고
    • The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
    • ANOLIK JH, CAMPBELL D, FELGAR RE et al.: The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis. Rheum. (2003) 48(2):455-459.
    • (2003) Arthritis Rheum. , vol.48 , Issue.2 , pp. 455-459
    • Anolik, J.H.1    Campbell, D.2    Felgar, R.E.3
  • 149
    • 1542358942 scopus 로고    scopus 로고
    • Rituximab: Expanding role in therapy for lymphomas and autoimmune diseases
    • RASTETTER W, MOLINA A, WHITE CA: Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Ann. Rev. Med. (2004) 55:477-503.
    • (2004) Ann. Rev. Med. , vol.55 , pp. 477-503
    • Rastetter, W.1    Molina, A.2    White, C.A.3
  • 150
    • 0033855859 scopus 로고    scopus 로고
    • Clinical trials of antibody therapy
    • GLENNIE MJ, JOHNSON PW: Clinical trials of antibody therapy. Immunol. Today (2000) 21(8):403-410.
    • (2000) Immunol. Today , vol.21 , Issue.8 , pp. 403-410
    • Glennie, M.J.1    Johnson, P.W.2
  • 151
  • 152
    • 2142714017 scopus 로고    scopus 로고
    • Monoclonal antibodies as therapeutic agents for cancer
    • HARRIS M: Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol. (2004) 5(5):292-302.
    • (2004) Lancet Oncol. , vol.5 , Issue.5 , pp. 292-302
    • Harris, M.1
  • 153
    • 0021272605 scopus 로고
    • Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation
    • ANDERSON K, BATES M, SLAUGHENHOUPT B, PINKUS GS, SCHLOSSMAN SF, NADLER LM: Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 63(6):1424-1433.
    • (1984) Blood , vol.63 , Issue.6 , pp. 1424-1433
    • Anderson, K.1    Bates, M.2    Slaughenhoupt, B.3    Pinkus, G.S.4    Schlossman, S.F.5    Nadler, L.M.6
  • 154
    • 0038014070 scopus 로고    scopus 로고
    • Randomized Phase III study for the treatment of advanced indolent non-Hodgkids lymphomas (NHL) and mantle cell lymphoma: Chemotherapy versus chemotherapy plus rituximab
    • HEROLD M, DOLKEN G, FIEDLER F et al.: Randomized Phase III study for the treatment of advanced indolent non-Hodgkids lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab. Ann. Hematol. (2003) 82(2):77-79.
    • (2003) Ann. Hematol. , vol.82 , Issue.2 , pp. 77-79
    • Herold, M.1    Dolken, G.2    Fiedler, F.3
  • 155
    • 0036464719 scopus 로고    scopus 로고
    • Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
    • CARTRON G, DACHEUX L, SALLES G et al.: Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood (2002) 99(3):754-758.
    • (2002) Blood , vol.99 , Issue.3 , pp. 754-758
    • Cartron, G.1    Dacheux, L.2    Salles, G.3
  • 156
    • 0037092951 scopus 로고    scopus 로고
    • Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: Results of a large international study
    • KEATING MJ, FLINN I, JAIN V et al.: Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood (2002) 99 10):3554-3561.
    • (2002) Blood , vol.99 , Issue.10 , pp. 3554-3561
    • Keating, M.J.1    Flinn, I.2    Jain, V.3
  • 157
    • 0141885088 scopus 로고    scopus 로고
    • Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H
    • ZHANG Z, ZHANG M, GOLDMAN CK, RAVETCH JV, WALDMANN TA: Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer. Res. (2003) 63(19):6453-6457.
    • (2003) Cancer Res. , vol.63 , Issue.19 , pp. 6453-6457
    • Zhang, Z.1    Zhang, M.2    Goldman, C.K.3    Ravetch, J.V.4    Waldmann, T.A.5
  • 158
    • 0024337144 scopus 로고
    • Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
    • SLAMONI DJ, GODOLPHIN W, JONES LA et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 244(4905):707-712.
    • (1989) Science , vol.244 , Issue.4905 , pp. 707-712
    • Slamoni, D.J.1    Godolphin, W.2    Jones, L.A.3
  • 159
    • 3042611780 scopus 로고    scopus 로고
    • Oncogenic growth factor receptors: Implications for signal transduction therapy
    • MOSESSON Y, YARDEN Y. Oncogenic growth factor receptors: implications for signal transduction therapy. Semin. Cancer Biol. (2004) 14(4):262-270.
    • (2004) Semin. Cancer Biol. , vol.14 , Issue.4 , pp. 262-270
    • Mosesson, Y.1    Yarden, Y.2
  • 161
    • 1842426004 scopus 로고    scopus 로고
    • Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes
    • KONO K, SATO E, NAGANUMA H et al.: Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes. Clin. Cancer. Res. (2004) 10(7):2538-2544.
    • (2004) Clin. Cancer Res. , vol.10 , Issue.7 , pp. 2538-2544
    • Kono, K.1    Sato, E.2    Naganuma, H.3
  • 163
    • 0036671332 scopus 로고    scopus 로고
    • Bispecific antibodies targeting cancer cells
    • PEIPP M, VALERIUS T: Bispecific antibodies targeting cancer cells. Biochem. Soc. Trans. (2002) 30(4):507-511.
    • (2002) Biochem. Soc. Trans. , vol.30 , Issue.4 , pp. 507-511
    • Peipp, M.1    Valerius, T.2
  • 164
    • 0033044588 scopus 로고    scopus 로고
    • Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
    • UMAÑA P, JEAN-MAIRET J, MOUDRY R, AMSTUTZ H, BAILEY JE: Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. (1999) 17(2):176-180.
    • (1999) Nat. Biotechnol. , vol.17 , Issue.2 , pp. 176-180
    • Umaña, P.1    Jean-Mairet, J.2    Moudry, R.3    Amstutz, H.4    Bailey, J.E.5
  • 165
    • 0027368961 scopus 로고
    • Recombinant soluble human Fcγ RII: Production, characterization, and inhibition of the Arthus reaction
    • IERINO FL, POWELL MS, MCKENIECK IF, HOGARTH PM: Recombinant soluble human Fcγ RII: production, characterization, and inhibition of the Arthus reaction. J. Exp. Med. (1993) 178(5):1617-1628.
    • (1993) J. Exp. Med. , vol.178 , Issue.5 , pp. 1617-1628
    • Ierino, F.L.1    Powell, M.S.2    McKenieck, I.F.3    Hogarth, P.M.4
  • 166
    • 0034972816 scopus 로고    scopus 로고
    • Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIB and is not associated with loci controlling diabetes
    • JOHANSSON AC, SUNDLER M, KJELLEN P et al.: Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIB and is not associated with loci controlling diabetes. Eur. J. Immunol. (2001) 31(6):1847-1856.
    • (2001) Eur. J. Immunol. , vol.31 , Issue.6 , pp. 1847-1856
    • Johansson, A.C.1    Sundler, M.2    Kjellen, P.3
  • 167
    • 1942499587 scopus 로고    scopus 로고
    • Fcγ receptors on mast cells: Activating and inhibitory regulation of mediator release
    • TRACZYK C, OKAYAMA Y, METCALFE DD, GLIFILLAN AM: Fcγ receptors on mast cells: activating and inhibitory regulation of mediator release. Int. Arch. Allergy Immunol. (2004) 133(3):305-315.
    • (2004) Int. Arch. Allergy Immunol. , vol.133 , Issue.3 , pp. 305-315
    • Traczyk, C.1    Okayama, Y.2    Metcalfe, D.D.3    Glifillan, A.M.4
  • 168
    • 0035983742 scopus 로고    scopus 로고
    • Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus
    • KYOGOKU C, DIJSTELBLOEM HM, TSUCHIYA N et al.: Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus. Arthritis Rheum. (2002) 46(5):1242-1254.
    • (2002) Arthritis Rheum. , vol.46 , Issue.5 , pp. 1242-1254
    • Kyogoku, C.1    Dijstelbloem, H.M.2    Tsuchiya, N.3
  • 169
    • 1842632236 scopus 로고    scopus 로고
    • Polymorphisms of the Fcγ receptor Type IIB gene are not associated with systemic lupus erythematosus in the Swedish population
    • MAGNUSSON V, ZUNEC R, ODEBERG J et al.: Polymorphisms of the Fcγ receptor Type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis. Rheum. (2004) 50(4):1348-1350.
    • (2004) Arthritis Rheum. , vol.50 , Issue.4 , pp. 1348-1350
    • Magnusson, V.1    Zunec, R.2    Odeberg, J.3
  • 170
    • 2442710233 scopus 로고    scopus 로고
    • A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus
    • SU K, WU J, EDBERG JC et al.: A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J. Immunol. (2004) 172(11):7186-7191.
    • (2004) J. Immunol. , vol.172 , Issue.11 , pp. 7186-7191
    • Su, K.1    Wu, J.2    Edberg, J.C.3
  • 171
    • 2442679050 scopus 로고    scopus 로고
    • A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function
    • SU K, LI X, EDBERG JC et al.: A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIB alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J. Immunol. (2004) 172(11):7192-7199.
    • (2004) J. Immunol. , vol.172 , Issue.11 , pp. 7192-7199
    • Su, K.1    Li, X.2    Edberg, J.C.3
  • 173
    • 0037187949 scopus 로고    scopus 로고
    • Immune thrombocytopenic purpura
    • CINES DB, BLANCHETTEI VS: Immune thrombocytopenic purpura. N. Engl. J. Med. (2002) 346(13):995-1008.
    • (2002) N. Engl. J. Med. , vol.346 , Issue.13 , pp. 995-1008
    • Cines, D.B.1    Blanchettei, V.S.2
  • 174
    • 0035436879 scopus 로고    scopus 로고
    • Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes
    • YUKI N: Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect. Dis. (2001) 1(1):29-37.
    • (2001) Lancet Infect. Dis. , vol.1 , Issue.1 , pp. 29-37
    • Yuki, N.1
  • 175
    • 0036259789 scopus 로고    scopus 로고
    • High-dose intravenous immunoglobulin treatment of multiple sclerosis
    • DURELLI L, ISOARDO G: High-dose intravenous immunoglobulin treatment of multiple sclerosis. Neurol. Sci. (2002) 23 Suppl, 1):S39-S48.
    • (2002) Neurol. Sci. , vol.23 , Issue.SUPPL. 1
    • Durelli, L.1    Isoardo, G.2
  • 176
    • 0034774825 scopus 로고    scopus 로고
    • Use of intravenous gamma globulins in neuroimmunologic diseases
    • LATOV N, CHAUDHRY V, KOSKI CL et al.: Use of intravenous gamma globulins in neuroimmunologic diseases. J. Allergy. Clin. Immunol. (2001) 108(4 Suppl.):S126-S132.
    • (2001) J. Allergy Clin. Immunol. , vol.108 , Issue.4 SUPPL.
    • Latov, N.1    Chaudhry, V.2    Koski, C.L.3
  • 177
    • 0036221826 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in neurological disease: A specialist review
    • WILES CM, BROWN P, CHAPEL H et al.: Intravenous immunoglobulin in neurological disease: a specialist review. J. Neurol. Neurosurg. Psychiatry (2002) 72(4):440-448.
    • (2002) J. Neurol. Neurosurg. Psychiatry , vol.72 , Issue.4 , pp. 440-448
    • Wiles, C.M.1    Brown, P.2    Chapel, H.3
  • 178
    • 0035230888 scopus 로고    scopus 로고
    • Kawasaki disease
    • BURNS JC: Kawasaki disease. Adv. Pediatr. (2001) 48 157-177.
    • (2001) Adv. Pediatr. , vol.48 , pp. 157-177
    • Burns, J.C.1
  • 179
    • 0036884344 scopus 로고    scopus 로고
    • Immunomodulatory action of intravenous immunoglobulin
    • SEWELL WA, JOLLES S: Immunomodulatory action of intravenous immunoglobulin. Immunology (2002) 107(4):387-393.
    • (2002) Immunology , vol.107 , Issue.4 , pp. 387-393
    • Sewell, W.A.1    Jolles, S.2
  • 180
    • 0038300763 scopus 로고    scopus 로고
    • IVIg - Mechanisms of action
    • SIMON HU, SPATH PJ: IVIg - mechanisms of action. Allergy (2003) 58(7):543-552.
    • (2003) Allergy , vol.58 , Issue.7 , pp. 543-552
    • Simon, H.U.1    Spath, P.J.2
  • 181
    • 0038377261 scopus 로고    scopus 로고
    • Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    • BAYRY J, MISRA N, LATRY V et al.: Mechanisms of action
    • (2003) Tansfus. Clin. Biol. , vol.10 , Issue.3 , pp. 165-169
    • Bayry, J.1    Misra, N.2    Latry, V.3
  • 182
    • 0035910392 scopus 로고    scopus 로고
    • Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
    • SAMUELSSON A, TOWERS TL, RAVETCH JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science (2001) 291(5503):484-486.
    • (2001) Science , vol.291 , Issue.5503 , pp. 484-486
    • Samuelsson, A.1    Towers, T.L.2    Ravetch, J.V.3
  • 183
    • 0037399064 scopus 로고    scopus 로고
    • Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease
    • BRUHNS P, SAMUELSSON A, POLLARD JW, RAVETCH JV: Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity (2003) 18(4):573-581.
    • (2003) Immunity , vol.18 , Issue.4 , pp. 573-581
    • Bruhns, P.1    Samuelsson, A.2    Pollard, J.W.3    Ravetch, J.V.4
  • 184
    • 0038494827 scopus 로고    scopus 로고
    • IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity
    • CROW AR, SONG S, FREEDMAN J et al.: IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood (2003) 102(2):558-560.
    • (2003) Blood , vol.102 , Issue.2 , pp. 558-560
    • Crow, A.R.1    Song, S.2    Freedman, J.3
  • 186
    • 0029875055 scopus 로고    scopus 로고
    • Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor
    • MCDONNEL JM, BEAVIL AJ, MACKAY GA et al.: Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat. Struct. Biol. (1996) 5 3):419-426.
    • (1996) Nat. Struct. Biol. , vol.5 , Issue.3 , pp. 419-426
    • Mcdonnel, J.M.1    Beavil, A.J.2    Mackay, G.A.3
  • 187
    • 0033911048 scopus 로고    scopus 로고
    • Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide
    • MARINO M, RUVO M, DE FALCO S, FASSINA G: Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide. Nat. Biotechnol. (2000) 18 7):735-739.
    • (2000) Nat. Biotechnol. , vol.18 , Issue.7 , pp. 735-739
    • Marino, M.1    Ruvo, M.2    De Falco, S.3    Fassina, G.4
  • 188
  • 189
    • 3843123356 scopus 로고    scopus 로고
    • Functional mapping of the FcγRII binding site on human IgG1 by synthetic peptides
    • MEDGYSEI D, URAY K, SALLAI K et al.: Functional mapping of the FcγRII binding site on human IgG1 by synthetic peptides. Eur. J. Immunol. (2004) 34(4):1127-1135.
    • (2004) Eur. J. Immunol. , vol.34 , Issue.4 , pp. 1127-1135
    • Medgysei, D.1    Uray, K.2    Sallai, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.